Newsletter - February 2, 2023
“Work From Home” No More: FDA Staff Returns to the Office This Month
Starting this month, FDA’s staff will return to their offices in White Oak, outside Washington DC, to a hybrid work-schedule reversing earlier indications from FDA leaders that work from home may become permanent. While it may seem like a big change in the post-pandemic world, it is not. FDA staff have maintained...Read More
FDA Audit Trends, 2023
Last year FDA inspections were down about 20% compared to years prior to 2019, and food facility inspections accounted for more inspections than all other facilities combined. The most common finding at drug and device manufacturing facilities was SOPs not present or not followed. There are a few other important...Read More
“Work From Home” No More: FDA Staff Returns to the Office This Month
Starting this month, FDA’s staff will return to their offices in White Oak, outside Washington DC, to a hybrid work-schedule reversing earlier indications from FDA leaders that work from home may become permanent. While it may seem like a big change in the post-pandemic world, it is not. FDA staff have maintained...Read More
FDA Audit Trends, 2023
Last year FDA inspections were down about 20% compared to years prior to 2019, and food facility inspections accounted for more inspections than all other facilities combined. The most common finding at drug and device manufacturing facilities was SOPs not present or not followed. There are a few other important...Read More
